Y-mAbs Therapeutics, Inc.: Please contact the Portnoy Law Firm to recover your losses; March 20, 2023 deadline
17 mars 2023 16h19 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 17, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc.: Please contact the Portnoy Law Firm to recover your losses; March 20, 2023 deadline
10 mars 2023 12h00 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 10, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc. (YMAB) Class Action Notice: Robbins LLP Urges Shareholders to Contact the Firm for Information Regarding Their Rights
08 mars 2023 11h57 HE
|
Robbins LLP
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
Y-mAbs Therapeutics, Inc.: Please contact the Portnoy Law Firm to recover your losses; March 20, 2023 deadline
16 févr. 2023 19h06 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc. (YMAB) Class Action Notice: Robbins LLP Urges Shareholders to Contact the Firm for Information Regarding Their Rights
09 févr. 2023 15h04 HE
|
Robbins LLP
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
Y-mAbs Therapeutics, Inc. (YMAB) Investor Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Class Action Against Y-mAbs Therapeutics, Inc.
02 févr. 2023 15h23 HE
|
Robbins LLP
SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
Y-mAbs Therapeutics, Inc. (YMAB) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Y-mAbs Therapeutics, Inc.
24 janv. 2023 14h31 HE
|
Robbins LLP
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
Y-mAbs Therapeutics, Inc.: Please contact the Portnoy Law Firm to recover your losses; March 20, 2023 deadline
22 janv. 2023 17h39 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 22, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Alert: Kaplan Fox & Kilsheimer LLP Notifies Y-mAbs Investors of a Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
19 janv. 2023 18h24 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Update: Kaplan Fox Continues to Investigate Potential Securities Fraud
02 déc. 2022 13h10 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc....